Abstract
Antiphospholipid syndrome (APS) is an autoimmune disease defined by accelerated atherosclerosis, arterial and venous thrombosis, fetal loss, and the presence of antiphospholipid antibodies (aPL) in the serum and which leads to the occurrence of various vascular events. Nonspecific abdominal pain can be one of the symptoms due to changes on visceral blood vessels. The goal of our work is to show the results we obtained in multidetector computed tomography (MDCT) angiography examination of visceral arteries, comparing patients with primary antiphospholipid syndrome (PAPS) and secondary antiphospholipid syndrome (SAPS) with control group. In this study, we analyzed 50 patients with primary PAPS and 50 patients, with secondary SAPS. The results were compared to 50 patients in the control group. The groups were compared in terms of age, gender, and the most common risk factors except for the lipid status, since controls had significantly higher levels of cholesterol and triglycerides. The study was conducted on 64-MDCT, on which we analyzed quantitative and morphological characteristics of the blood vessel lesions. Patients from the control group had statistically significant elevation of cholesterol and triglyceride levels compared to the patients with SAPS and PAPS (p < 0.001 and p < 0.05). The results showed that the frequency of changes is statistically (p < 0.05 and p < 0.001) more common in patients with PAPS and SAPS than in the control group. Statistically significant difference between the groups was found in superior and inferior mesentery arteries. Analyzing the number of lesions, there was statistically high difference between the patients with one and two lesions than in patients with four or more lesions (p < 0.001), lower difference compared to the patients with three lesions (p < 0.01), while there was low, but yet statistically important difference between the patients with three lesions and those with five or more blood vessel lesions (p < 0.05). Analyzing percentage of diameter stenosis, we established that the lesions in the groups of 0–30% diameter stenosis (DS) and 30–50% DS in patients with PAPS (n = 42) and SAPS (n = 44) are more common than in the control group (n = 18, p < 0.05). Analyzing the qualitative characteristics of plaques, we established significantly higher frequency of soft tissue and mixed lesions than calcified ones in patients with PAPS and SAPS (p < 0.001; p < 0.05). Our study showed that the subclinical manifestation of the changes on visceral arteries is more common in patients with APS. Patients with abdominal pain were those with two or more lesions, and according to our results, majority had PAPS. Because of its safety and accuracy, the method of choice is MDCT angiography in monitoring the progression of disease.
Similar content being viewed by others
References
Lockshin MD, Sammartino LR, Schwartzman S. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum. 2000;43:440–3.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4(2):295–306.
Rovensky J. Asheron’s syndrome - catastrophic antipospholipid syndrome. Autoimmun Rev. 2006;6:61–3.
Shoenfeld Y, Sherer Y, Haratz D. Atherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 2001;22:293–5.
Ames PR, Margarita A, Sokoll KB, Weston M, Brancaccio V. Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis. 2005;64:315–7.
Ruiz-Irastorza G, Crowther M, Branch W, Khamashta MA. Antiphospholipid syndrome. Lancet. 2010;376:1498.
Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases—2008. Isr Med Assoc J. 2008;10(1):8–12.
Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337–47.
Krause I, Blank M, Stojanovich L, et al. The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome. Immunobiology. 2005;210:749–54.
Jiménez S, García-Criado MA, Tàssies D, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology. 2005;44:756–61.
Soltész P, Szekanecz Z, Kiss E, Shoenfeld Y. Cardiac manifestations in antiphospholipid syndrome. Autoimmun Rev. 2007;6(6):379–86.
Saponjski J, Stojanovich L, Djokovic A, Petkovic M, Mrda D. Systemic vascular diseases in the antiphospholipid syndrome. What is the best diagnostic choice? Autoimmun Rev. 2011;10(4):235-7.
Lalani TA, Kanne JP, Hatfield GA, Chen P. Imaging findings in systemic lupus erythematosus. Radiographics. 2004;24(4):1069–86.
Laswed T, Rizzo E, Guntern D, Doenz F, Denys A, Schnyder P, et al. Assessment of occlusive arterial disease of abdominal aorta and lower extremities arteries: value of multidetector CT angiography using an adaptive acquisition method. Eur Radiol. 2008;18(2):263–72.
Kaushik S, Federle M, Schur PH, Krishnan M, Silverman SG, Ros PR. Abdominal thrombotic and ischemic manifestations of the antiphospholipid antibody syndrome: CT findings in 42 patients. Radiology. 2001;218:768–7.
Beregi JP, Djabbari M, Desmoucelle F, Willoteaux S, Wattinne L, Louvegini S. Popliteal vascular disease: evaluation with spiral CT angiography. Radiology. 1997;203:477–83.
Verbeeck N, Cavez N, Plawny L, Weber J, Lens V. Primary aortic thrombosis: role of enhanced multislice CT demonstrated in three exceptional cases. JBR-BTR. 2014;97(2):76–80.
Suzuki K, Uemura T, Kikuchi M, Ishihara Y, Ichioka S. Acute limb-threatening ischemia associated with antiphospholipid syndrome: a report of two cases. J Foot Ankle Surg. 2016;55(5):976-9.
Padricelli A, Giribono AM, Ferrara D, Spalla F, Bracale U, Del Guercio L, Servillo G, Ruotolo C, Bracale UM. Severe mesenteric ischemia in a pregnant woman with antiphospholipid syndrome. Ann Vasc Surg. 2017;44:415.e11-415.e16.
Paliogiannis P, Ginesu GC, Feo CF, Cossu ML, Pinna A, Farina G, Vidili G, Porcu A. Surgical treatment of chronic multivascular mesenteric ischemia in a patient with antiphospholipid syndrome, abdominal aortic aneurism, and renal cancer: when planning overwhelms complexity. Ann Ital Chir. 2016;5.
Salaun E, Bartoli MA, Soler R, Khibri H, Ebbo M, Bernit E, et al. Severe symptomatic stenosis of visceral and renal arteries leading primary antiphospholipid syndrome diagnosis. Ann Vasc Surg. 2014;28(7):1796.e9-1796.e13.
Crome CR, Rajagopalan S, Kuhan G, and Fluck N. Rare disease. Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus. BMJ Case Rep. 2012; 2012:
Senatore FJ, McDonald KJ. Gastrointestinal: ischemic gastrointestinal manifestations in a young adult: implicating a rare initial presentation of antiphospholipid syndrome. Gastroenterol Hepatol. 2016;31(8):1381.
Crome CR, Rajagopalan S, Kuhan G, Fluck N. Antiphospholipid syndrome presenting with acute digital ischaemia, avascular necrosis of the femoral head and superior mesenteric artery thrombus. BMJ Case Rep. 2012;2012.
Sitia S, Atzeni F, Sarzi-Puttini P, Di Bello V, Tomasoni L, Delfino L, et al. Cardiovascular involvement in systemic autoimmune diseases. Autoimmun Rev. 2009;8(4):281–6.
Langenberger H, Schillinger M, Plank C, Sabeti S, Dick P, Cejna M, et al. Agreement of duplex ultrasonography vs computed tomography angiography for evaluation of native and in-stent SFA re-stenosis—findings from a randomized controlled trial. Eur J Radiol. 2012;81(9):2265–9.
Saponjski J, Stojanovich L, Petrovic J, Saponjski D. The role of MSCT angiography in early detection of lower limb arterial lesions in patients with antiphospholipid syndrome. Immunol Res. 2017;65(2):482–6.
Nardi P, Pellegrino A, Romagnoli A, Mve Mvondo C, De Propris S, Sperandio M, et al. Multidetector computed tomographic coronary angiography as an alternative to conventional coronary angiography in non-coronary surgical patients. J Cardiovasc Surg. 2011;52(3):429–35.
Van den Bosch H, Westenberg J, Setz-Pels W, Kersten E, Tielbeek A, Duijm L, Post J, Teijink J, de Roos A. Prognostic value of cardiovascular MR imaging biomarkers on outcome in peripheral arterial disease: a 6-year follow-up pilot study. Int J Cardiovasc Imag. 2016;32(8):1281-8.
Lin YH, Lin HH, Liu HM, Lee CW, Chen YF. Diagnostic performance of CT and MRI on the detection of symptomatic intracranial dural arteriovenous fistula: a meta-analysis with indirect comparison. Neuroradiology. 2016;58(8):753-63.
Cina A, Di Stasi C, Semeraro V, Marano R, Savino G, Iezzi R, et al. Comparison of CT and MR angiography in evaluation of peripheral arterial disease before endovascular intervention. Acta Radiol. 2016;57(5):547–56.
Jimenez S, Garcia-Criado A, Tassies D, et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology. 2005;44:756–61.
Acknowledgements
We thank all patients who participated in this study and our colleagues from many clinics in Serbia. This work was supported by research grant number 175041, issued by the Ministry of Science of the Republic of Serbia.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflicts of interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Saponjski, J., Stojanovich, L., Saponjski, J. et al. Abdominal pain in patient with antiphospholipid syndrome—the role of MDCT angiography on visceral blood vessels. Immunol Res 65, 1150–1155 (2017). https://doi.org/10.1007/s12026-017-8968-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12026-017-8968-1